Page last updated: 2024-12-07

n,n-dimethyl-1-methyldodecylamine oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N,N-dimethyl-1-methyldodecylamine oxide: tested for antimicrobial & cytolytic activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID124727
SCHEMBL ID3294127
MeSH IDM0071754

Synonyms (21)

Synonym
60729-78-4
nsc291914
nsc-291914
brn 4244713
2-tridecanamine, n,n-dimethyl-, n-oxide
1-(metyldodecyl)dimetylamin-n-oxid [czech]
n,n-dimethyl-1-methyldodecylamine oxide
n,n-dimethyl-2-tridecanamine n-oxide
1-(methyldodecyl)dimethylamine-n-oxide
unii-84s9z2150k
nsc 291914
84s9z2150k ,
1-(metyldodecyl)dimetylamin-n-oxid
SCHEMBL3294127
n,n,1-trimethyldodecylamine n-oxide
(1-methyldodecyl)dimethylamine oxide
(1-methyldodecyl)dimethylamine n-oxide
n-(1-methyldodecyl)-n,n-dimethylamine oxide
1-methyldodecyldimethylamine oxide
Q27269548
DTXSID401027883
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (36.36)18.7374
1990's5 (45.45)18.2507
2000's2 (18.18)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.72 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]